Xponance Inc. Boosts Position in The Cooper Companies, Inc. (NASDAQ:COO)

Xponance Inc. grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 5.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,098 shares of the medical device company’s stock after acquiring an additional 1,656 shares during the period. Xponance Inc.’s holdings in Cooper Companies were worth $2,951,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Fulton Bank N.A. lifted its holdings in Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares during the period. Torray Investment Partners LLC increased its holdings in shares of Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after purchasing an additional 132 shares in the last quarter. Mather Group LLC. lifted its stake in shares of Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB boosted its holdings in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after buying an additional 136 shares in the last quarter. Finally, Greenleaf Trust increased its holdings in Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after buying an additional 139 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 1.6 %

Shares of COO stock opened at $81.71 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $77.05 and a fifty-two week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock’s fifty day moving average is $90.05 and its two-hundred day moving average is $98.14. The firm has a market capitalization of $16.34 billion, a P/E ratio of 41.90, a PEG ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on COO shares. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Morgan Stanley dropped their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Stifel Nicolaus cut their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.